United Therapeutics Balance Sheet (2009-2026) | UTHR

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)	942.20M	908.50M	894.80M	813.30M	795.20M	966.80M	961.20M	1,163.50M	1,067.30M	1,107.70M	1,207.70M	1,251.50M	1,355.70M	1,553.90M	1,697.20M	1,899.90M	1,593.10M	1,340.10M	1,557.10M	1,279.70M
Short-term Investments (Quarter)	1,025.30M	1,091.90M	1,035.90M	1,454.40M	1,460.00M	1,648.80M	1,877.50M	1,699.90M	1,611.70M	1,767.80M	1,786.40M	1,456.30M	1,615.80M	1,772.60M	1,569.80M	1,421.40M	1,455.60M	1,427.50M	1,363.20M	874.00M
Cash & Current Investments (Quarter)	1,967.50M	2,000.40M	1,930.70M	2,267.70M	2,255.20M	2,615.60M	2,838.70M	2,863.40M	2,679.00M	2,875.50M	2,994.10M	2,707.80M	2,971.50M	3,326.50M	3,267.00M	3,321.30M	3,048.70M	2,767.60M	2,920.30M	2,153.70M
Receivables - Net (Quarter)	173.40M	212.80M	198.70M	170.50M	173.40M	231.70M	220.40M	134.50M	272.70M	258.60M	278.90M	307.30M	290.70M	341.80M	279.30M	322.00M	379.30M	297.70M	350.20M	312.00M
Receivables (Quarter)	173.40M	212.80M	198.70M	170.50M	173.40M	231.70M	220.40M	134.50M	272.70M	258.60M	278.90M	307.30M	290.70M	341.80M	279.30M	322.00M	379.30M	297.70M	350.20M	312.00M
Raw Materials (Quarter)
Work In Process (Quarter)
Finished Goods (Quarter)
Inventory (Quarter)	89.90M	96.70M	93.80M	88.20M	89.90M	91.00M	102.00M	102.50M	103.30M	104.30M	111.80M	120.20M	136.50M	146.70M	157.90M	165.40M	169.20M	176.50M	183.10M	178.30M
Current Deferred Tax Assets (Quarter)
Prepaid Assets (Quarter)	87.10M	76.00M	100.40M	60.20M	165.80M	118.10M	219.20M	92.60M	158.40M	220.50M	166.20M	113.40M	220.80M	185.40M	169.70M	131.10M	229.70M	252.20M	248.90M	228.00M
Current Assets (Quarter)	2,317.90M	2,385.90M	2,323.60M	2,586.60M	2,684.30M	3,056.40M	3,380.30M	3,193.00M	3,213.40M	3,458.90M	3,551.00M	3,248.70M	3,619.50M	4,000.40M	3,873.90M	3,939.80M	3,826.90M	3,494.00M	3,702.50M	2,872.00M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	715.70M	726.70M	780.90M	784.40M	791.40M	840.80M	861.50M	896.50M	938.90M	992.20M	1,045.40M	1,074.00M	1,094.60M	1,156.70M	1,222.40M	1,302.70M	1,362.40M	1,555.60M	1,729.70M	1,840.70M
Long-Term Investments (Quarter)	1,325.40M	1,508.70M	1,649.90M	1,559.10M	1,641.90M	1,443.80M	1,316.20M	1,765.60M	2,023.60M	2,060.80M	1,909.80M	1,491.90M	1,330.40M	1,279.40M	1,475.30M	1,710.70M	1,917.70M	1,567.30M	1,776.70M	1,317.40M
Goodwill (Quarter)	28.00M	28.00M	28.00M	28.00M	28.00M	28.00M	28.00M				33.70M			4.30M	32.30M				32.30M
Intangibles (Quarter)
Goodwill & Intangibles (Quarter)	44.70M	44.70M	44.60M	44.60M	44.60M	44.50M	44.50M	44.50M	44.50M	44.40M	114.20M	115.40M	115.20M	112.10M	111.90M	111.70M	111.50M	116.70M	116.50M	115.50M
Long-Term Deferred Tax (Quarter)	264.20M	273.90M	261.90M	271.80M	275.30M	281.30M	327.70M	321.90M	325.60M	325.60M	394.80M	396.10M	395.60M	390.90M	458.40M	456.60M	456.20M	354.90M	357.70M	335.40M
Other Non-Current Assets (Quarter)	177.00M	109.00M	108.20M	113.30M	105.80M	114.80M	114.30M	124.50M	135.30M	141.70M	151.80M	169.10M	167.90M	183.60M	222.10M	222.40M	233.30M	262.60M	196.90M	233.20M
Non-Current Assets (Quarter)	2,527.00M	2,663.00M	780.90M	2,773.20M	2,859.00M	2,725.20M	883.70M	3,153.00M	3,467.90M	3,564.70M	1,069.80M	3,246.50M	3,103.70M	3,122.70M	3,490.10M	3,804.10M	4,081.10M	3,857.10M	4,177.50M	3,842.20M
Assets (Quarter)	4,844.90M	5,048.90M	5,169.10M	5,359.80M	5,543.30M	5,781.60M	6,044.50M	6,346.00M	6,681.30M	7,023.60M	7,167.00M	6,495.20M	6,723.20M	7,123.10M	7,364.00M	7,743.90M	7,908.00M	7,351.10M	7,880.00M	6,714.20M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	189.80M	210.50M	174.60M	166.40M	196.60M	220.10M	229.90M	239.70M	292.00M	333.40M	298.00M	305.10M	325.30M	363.90M	344.50M	367.00M	432.00M	468.00M	488.00M	498.30M
Notes Payables (Quarter)
Payables (Quarter)	189.80M	210.50M	174.60M	166.40M	196.60M	220.10M	229.90M	239.70M	292.00M	333.40M	298.00M	305.10M	325.30M	363.90M	344.50M	367.00M	432.00M	468.00M	488.00M	498.30M
Accumulated Expenses (Quarter)			170.80M				225.80M				292.40M				338.50M				480.90M
Other Accumulated Expenses (Quarter)	24.80M	26.00M	28.40M	60.80M	39.60M	35.70M	32.50M	38.60M	37.80M	70.10M	71.00M	126.30M	77.80M	80.10M	93.60M	154.50M	95.10M	78.30M	72.60M	100.80M
Short term Debt (Quarter)										300.00M	400.00M	400.00M	400.00M	400.00M	300.00M	200.00M
Current Leases (Quarter)
Total Current Liabilities (Quarter)	311.40M	320.00M	305.40M	292.60M	331.50M	315.90M	343.20M	324.60M	370.30M	744.10M	804.40M	860.60M	832.30M	873.40M	738.10M	721.50M	527.10M	546.30M	560.60M	599.10M
Non-Current Liabilities
Capital Leases (Quarter)
Non-Current Debt (Quarter)	800.00M	800.00M	800.00M	800.00M	800.00M	800.00M	800.00M	800.00M	800.00M	500.00M	300.00M	200.00M	100.00M
Convertible Debt (Quarter)
Pension (Quarter)
Preferred Stock Liabilities (Quarter)
Minority Interest (Quarter)
Other Non-Current Liabilities (Quarter)	94.00M	99.20M	104.80M	90.90M	93.40M	103.50M	104.60M	98.20M	100.00M	67.40M	77.80M	96.50M	93.70M	148.80M	181.90M	215.20M	207.30M	214.60M	223.20M	214.00M
Total Non-Current Liabilities (Quarter)	1,111.40M	1,120.00M	1,105.40M	1,092.60M	1,131.50M	1,115.90M	1,143.20M	1,124.60M	1,170.30M	1,244.10M	1,104.40M	1,060.60M	932.30M	873.40M	738.10M	721.50M	527.10M	546.30M	560.60M	599.10M
Total Liabilities (Quarter)	1,205.40M	1,219.20M	1,210.20M	1,183.50M	1,224.90M	1,219.40M	1,247.80M	1,222.80M	1,270.30M	1,311.50M	1,182.20M	1,157.10M	1,026.00M	1,022.20M	920.00M	936.70M	734.40M	760.90M	783.80M	813.10M
Shareholder's Equity
Total Debt (Quarter)	800.00M	800.00M	800.00M	800.00M	800.00M	800.00M	800.00M	800.00M	800.00M	800.00M	700.00M	600.00M	500.00M	400.00M	300.00M	200.00M
Common Equity (Quarter)	3,639.50M	3,829.70M	3,958.90M	4,176.30M	4,318.40M	4,562.20M	4,796.70M	5,123.20M	5,411.00M	5,712.10M	5,984.80M	5,338.10M	5,697.20M	6,100.90M	6,444.00M	6,807.20M	7,173.60M	6,590.20M	7,096.20M	5,901.10M
Shareholder's Equity (Quarter)	3,639.50M	3,829.70M	3,958.90M	4,176.30M	4,318.40M	4,562.20M	4,796.70M	5,123.20M	5,411.00M	5,712.10M	5,984.80M	5,338.10M	5,697.20M	6,100.90M	6,444.00M	6,807.20M	7,173.60M	6,590.20M	7,096.20M	5,901.10M
Liabilities and Shareholders Equity (Quarter)	4,844.90M	5,048.90M	5,169.10M	5,359.80M	5,543.30M	5,781.60M	6,044.50M	6,346.00M	6,681.30M	7,023.60M	7,167.00M	6,495.20M	6,723.20M	7,123.10M	7,364.00M	7,743.90M	7,908.00M	7,351.10M	7,880.00M	6,714.20M
Treasury Shares (Quarter)	0.39M	0.40M	26.62M	0.37M	0.49M	26.62M	26.62M	26.62M	26.62M	0.94M	0.96M	1.21M	0.18M	30.17M	30.17M	30.17M	1.43M	1.42M	1.42M	1.42M
Retained Earnings (Quarter)	4,040.10M	4,202.80M	4,315.00M	4,554.90M	4,670.90M	4,910.20M	-55.50M	5,283.20M	-50.60M	5,810.00M	-12.80M	-15.60M	6,611.80M	7.40M	7,222.20M	7,544.40M	7,853.90M	8,192.60M	0.90M	-10.20M

Research Tools

United Therapeutics Balance Sheet (2009-2026) | UTHR

Create an account

Sign In

Reset Password